In non-tumor contexts, targeting ICAM1 (intercellular adhesion molecule 1) on HIV-1 viruses encapsulated in EVs can hinder their spread to T cells by preventing binding to the specific integrin FLA1 [232]. This evidence concerns the gene ICAM1 and neoplasm.